Do you provide value as a MSL? Part 2
- kimabc2112
- 2 days ago
- 1 min read
Continuing the conversation from my last post…
At the recent Medical Affairs Professional Society (MAPS) meeting, this was a topic of multiple sessions. One discussed target population outputs, which are short-term measures of tangible impact on the broader healthcare system. The goal is to determine how your conversation impacted patients through increased screening, referrals to a specialist, entry into a treatment protocol, etc.
Another session talked about the ability to evaluate changes in clinical practice and the implications of those changes. Alternatively, one session included a variety of metrics including the KOL’s opinion on specific aspects of the value proposition of the product and the available evidence, sentiment metrics, and then the behavior change seen through reported impacts. The combination of these will vary on the objectives of the team.
How can we determine these outcomes?
Measuring value is non-negotiable. I suspect leadership is asking for this information and if they aren’t now, they will eventually. The art of being an impactful MSL is to know what impact is important and making it happen with your scientific exchange.
Do you agree this is a complicated topic not only for MSLs but also for management as they report your impact to their leadership? How is your company navigating these challenges?
